Since its foundation in 2001, emovis has been able to prove itself as an experienced service provider in the field of clinical trials and has been awarded various prizes.
INC Research collaborates with more than 10,000 sites worldwide. Only 50 each are recognized for outstanding performance in spring and fall. in 2016 emovis was selected from more than 10,000 sites. Opinions of the clinical monitors on the evaluation process are decisive. Based on these opinions it is determined why a site has earned the award, and/or in which way the site provides excellent support to the monitors and enables the success of the project. In the case of emovis it had to be the "Alkermes" project, which is also a Success story for the team, regardless of the award.
The nice award, a tasteful transparent plaque engraved on dark background has now received a place of honor at emovis; in the CRA office on the first floor. Next to the awards granted by Pfizer, PAREXEL und Quintiles. emovis strives everyday, to justify the "Hall of Fame" and to consistently increase it. The membership at SCRS has been awarded as a brownie point in addition to the Clinical Research Site Award. emovis also appreciates this gesture very much.
The granting of the Innovation DEN Award is a fixed component and is becoming a tradition of the congress "Partnership in Clinical Trials (PCT)". It is awarded annually for outstanding ideas capable of substantially improving the conduct of clinical studies. In 2015, the award went to Wenke Schult for developing the division emovis Homecare Visits.
A prize for emovis Homecare Visits
The idea of conducting homecare visits within the scope of clinical studies decidedly improves the lives of precisely severely ill or immobile patients. The jury in 2015 must have thought that too when they awarded Wenke Schult the prize.
An FDA inspection is considered one of the toughest inspections in clinical research. Numerous seminars are offered to prepare precisely for this event. emovis has been subjected to the Inspection Format 438 without attending a seminar in 2013. emovis is still proud of the results today and obligates its team to continuously put their best foot forward in each study.